Document Detail

Evidence of mitigated calcification of the Mosaic versus Hancock Standard valve xenograft in the mitral position of young sheep.
MedLine Citation:
PMID:  17059935     Owner:  NLM     Status:  MEDLINE    
OBJECTIVES: Durability remains the main problem of all bioprosthetic valves, and calcification is the major cause of failure. New tissue treatment processes are expected to reduce mineralization. A comparative animal study was undertaken to evaluate the behavior of a new-generation porcine bioprosthesis in contrast with a first-generation porcine bioprosthesis. The primary goal was to evaluate the efficacy of alpha-amino-oleic acid as an anticalcification treatment. METHODS: Seventeen Targhee sheep (aged 4.5-7 months) had a mitral valve replacement with a Mosaic or Hancock Standard. The animals were followed up to 20 weeks (144.1 +/- 4.0 days vs 144.3 +/- 8.2 days) and then euthanized as scheduled. After gross examination, the explants were radiographed for the presence of calcification. The central portions were preserved for histologic examination, and the remainder of the sample was analyzed for quantitative calcium content by atomic absorption spectroscopy. RESULTS: Four Mosaic sheep were excluded because of perioperative surgical mortality. The remaining 13 were enrolled in the study (9 Mosaic and 4 Hancock Standard). The mean calcium content was 1.97 +/- 2.21 microg/mg tissue weight for Mosaic versus 8.36 +/- 4.12 microg/mg for Hancock Standard valves (P < .01). Mild fibrous tissue overgrowth and fibrinous lining were observed regardless the xenograft type. CONCLUSIONS: The low level of calcification in the Mosaic versus Hancock Standard xenografts confirms the efficacy of alpha-amino-oleic acid treatment in mitigating mineralization. A longer durability is expected with the clinical use of the Mosaic porcine valve.
Patricia A Weber; Jérôme Jouan; Akira Matsunaga; Elena Pettenazzo; Thomas Joudinaud; Gaetano Thiene; Carlos M G Duran
Related Documents :
19156225 - Altered energy homeostasis and resistance to diet-induced obesity in krap-deficient mice.
4363965 - Inhibition of free fatty acid mobilization by colchicine.
2020745 - Metabolism of oxidized linoleic acid: distribution of activity for the enzymatic oxidat...
9029635 - Simultaneous measurement of the rates of appearance of palmitic and linoleic acid in cr...
176005 - Studies on hyaluronic acid. v. relationship between the protein content and viscosity o...
2235835 - Lipid metabolism in liver of chicks: response to feeding.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The Journal of thoracic and cardiovascular surgery     Volume:  132     ISSN:  1097-685X     ISO Abbreviation:  J. Thorac. Cardiovasc. Surg.     Publication Date:  2006 Nov 
Date Detail:
Created Date:  2006-10-24     Completed Date:  2006-11-27     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0376343     Medline TA:  J Thorac Cardiovasc Surg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1137-43     Citation Subset:  AIM; IM    
International Heart Institute of Montana Foundation at Saint Patrick Hospital and Health Sciences Center and The University of Montana, Missoula, Mont, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cardiovascular Agents / pharmacology
Disease Models, Animal
Heart Valve Diseases*
Heart Valve Prosthesis*
Heart Valve Prosthesis Implantation
Mitral Valve
Models, Cardiovascular
Oleic Acid / pharmacology
Oleic Acids / pharmacology
Reg. No./Substance:
0/Cardiovascular Agents; 0/Oleic Acids; 112-80-1/Oleic Acid; 56472-43-6/2-(amino)oleic acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Expression of neuronal nitric oxide synthase in the internal thoracic artery and saphenous vein.
Next Document:  Temporary coronary artery occlusion during off-pump coronary artery bypass grafting with the new pol...